I concur with your sentiments on this jewel. I bought right after Dr. Williams newsletter came out at 4 and watched it soar to 12 and back down again. Then I participated in another private placement at 4 with warrants. Mike Barbour, the CEO has done an outstanding job of keeping this company afloat in the face of the GD FDA intransigence. I mean, here's a product (the Microlite 830) that WORKS, has no side effects, can save US industry billions in CTS claims, and they keep sitting on their fat butts asking for more and more data. Could it be that only billion dollar pharmaceutical firms get to foist their dangerous drugs on us while harmless, proven therapies languish?
What a useless agency!!
If Mike Barbour hadn't pulled off the Henley acquisition, LMDX could very well be in bankruptcy, now. As it is, they have a comfortable, profitable cushion, independent of the laser. But when that finally comes through, as it must, watch this baby soar! Meanwhile, look for momentary listing on NASDAQ Small Cap. |
